Bharat Biotech to launch Covaxin in Q2 2021
Posted by
www.biotecnika.org
The company's vaccine candidate -Covaxin- has been developed in
collaboration with the Indian Council of Medical Research (ICMR) -
National Institute of Virology (NIV) using inactivated Sars-Cov-2, the
virus that causes COVID-19.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bharat-biotech-to-launch-covaxin-in-q2-2021/articleshow/78979220.cms
Subscribe to:
Post Comments (Atom)
December 17, 2024 at 5:17 AM
Bharat Biotech’s Covaxin launch in Q2 is an exciting step toward combating the ongoing health crisis. As a student juggling multiple tasks, I often find it challenging to stay on top of everything. This is why I sometimes choose to hire someone to do my class for me. It’s a smart way to balance priorities while ensuring I stay on track with my academic responsibilities.
Post a Comment